Moreover, 11.54 % of patients had mutations in AXIN1, BCL6 Corepressor (BCOR), catenin beta 1 (CTNNB1), Fanconi Anemia Complementation Group E (FANCE), Fanconi anemia, complementation group M (FANCM), and nuclear receptor corepressor 1 (NCOR1) genes (An et al., 2019[4]). This evidence concerns the gene AXIN1 and Fanconi anemia.